Biohaven Appoints Jim Engelhart as Chief Financial Officer
May 09, 2016 03:06 ET
|
Biohaven Pharmaceutical Holding Company Limited
NEW HAVEN, Conn., May 9, 2016 (GLOBE NEWSWIRE) -- via PRWEB - The Board of Directors of Biohaven Pharmaceutical Holding Company Ltd. (d/b/a Biohaven) is pleased to announce the appointment of Jim...
Biohaven Announces Orphan Drug Designation Request Granted for the Treatment of Spinocerebellar Ataxia
March 03, 2016 09:53 ET
|
Biohaven Pharmaceutical Holding Company Limited
BRITISH VIRGIN ISLANDS, March 3, 2016 (GLOBE NEWSWIRE) -- via PRWEB - Company Receives Orphan Drug Designation Request for Spinocerebellar Ataxia Covering BHV-0223
Biohaven Pharmaceutical Holding...
Biohaven Announces Expedited Development Path for BHV-0223 Following Successful Pre-IND Interaction With FDA
February 25, 2016 07:10 ET
|
Biohaven Pharmaceutical Holding Company Limited
BRITISH VIRGIN ISLANDS, Feb. 25, 2016 (GLOBE NEWSWIRE) -- via PRWEB - Company Plans for Timely Completion of Bioequivalence Study and NDA Submission
Biohaven Pharmaceutical Holding Company Ltd....
Biohaven Announces Positive Results from Phase 1 Study with BHV-0223
February 24, 2016 03:08 ET
|
Biohaven Pharmaceutical Holding Company Limited
BRITISH VIRGIN ISLANDS, Feb. 24, 2016 (GLOBE NEWSWIRE) -- via PRWEB - Biohaven Pharmaceutical Holding Company Limited (d/b/a Biohaven) announced today positive results from a Phase I study with...
Biohaven Announces Phase 1 Pharmacokinetic Study Meets Study Objectives and Supports Advancing BHV-0223
November 19, 2015 17:06 ET
|
Biohaven Pharmaceutical Holding Company Limited
BRITISH VIRGIN ISLANDS, Nov. 19, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Biohaven Pharmaceutical Holding Company Limited (d/b/a Biohaven) announced today that preliminary results from a Phase I study...
Biohaven Appoints Vlad Coric M.D. as Chief Executive Officer
November 19, 2015 03:09 ET
|
Biohaven Pharmaceutical Holding Company Limited
NEW HAVEN, Conn., Nov. 19, 2015 (GLOBE NEWSWIRE) -- via PRWEB - The Board of Directors of Biohaven Pharmaceutical Holding Company Limited (d/b/a Biohaven) is pleased to announce the election of Vlad...